As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, Abcam offers highly validated biological binders and assays to address important targets in critical biological pathways.

ABS provides human biospecimens, cell culture scale up, and biobanking services.  ABS can extensively process and characterize the cells and tissues that we provide.  For example, we prepare cell membranes and other cell fractions, RNA, DNA, lysates, and proteins.  Likewise, we can analyze samples with Westerns, RT-qPCR, or immunohistochemistry.

ACT Genomics is a leading cancer molecular information service provider to support biomarker exploration and patient stratification (using NGS panel and CHIP-based multiplex PCR platform) in our CAP-accredited laboratory. Our unique IO biomarker solutions provide both DNA and RNA level data to biopharma developing immune checkpoint inhibitors.

ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell-and tissue-based research and diagnostic tests for personalized medicine. 

Agilent Technologies Inc. is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. Agilent employs about 13,500 people worldwide.

AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels. Organotypic assays with animal model-like complexities using human cells have been developed (eg. immune checkpoint, T-cell killing, angiogenesis, metastasis, cell migration, blood-brain barrier, etc.) for research, drug discovery & diagnostics.

We at Allevi are super excited about creating a new future for tissue engineering, organoid bioengineering, and biology. We are doing this by empowering scientist to create 3D tissues using our platform bioprinters. 

Almac Diagnostic Services is a stratified medicine company specialising in biomarker driven clinical trials. Our diagnostic experience spans oncology, immunology, CNS & infective diseases. Our global laboratories offer tailored solutions from discovery to commercialisation: Biomarker discovery. Custom assay development & validation. Flexible CDx development & commercialisation. www.almacgroup.com/diagnostics

Altis Biosystems, Inc. is a biotechnology company whose patent-pending stem cell platform recreates the human intestinal epithelium in a high-throughput format for drug screening and microbiome research. Altis's stem cells are isolated directly from transplant-grade, adult human, donor organs. Altis provides cell-based assay services or it can ship its platform.

AMRI, a global contract research and manufacturing organization. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.

AnaBios helps ensure the safety and efficacy of novel compounds through its advanced, human-focused translational technologies. In addition to working with Fortune 500 biotech companies, CROs and academia, AnaBios drives an internal drug discovery platform via in-licensed programs from partners in the pharmaceutical industry.

Applied StemCell is a fast-growing Gene/Cell Therapy Preclinical CRO headquartered in Milpitas, California.

Cell line models (oncology/CNS/iPSC)
Antibody screening, production
iPSC Preclinical Study includes Drug discovery, Neurotoxicology study, and Phenotype analysis
Mouse/rat models
Potency assay development (DNA, RNA, Protein, Animal Models)
CMC support
POC/IND-Enabling

ArcherDX addresses the bottlenecks associated with using next-generation sequencing in translational research by offering a robust platform for targeted sequencing applications.

Sought-after experts in purification of highly-pure, highly-active native proteins from human and animal plasma, erythrocytes, neutrophils, and tissues for studies of inflammation, autoimmune disease, cancer, coronary disease, Alzheimer’s Disease and more.  We offer these proteins as components for diagnostic kits, screenings, cell-culture media and for animal model proof-of-concept studies.
.

Aurelia Bioscience is a UK based contract research organisation specialising in bioassay development, pharmacological profiling and compound screening. Scientists at Aurelia Bioscience have decades of experience in pre-clinical discovery, designing and developing low, medium and high throughput assays for pharmacological profiling, hits-to-lead, lead identification and lead optimisation.

Axion BioSystems’ Maestro™ is the industry’s first high-throughput microelectrode array (MEA) system that records networks of electrically active cells. Perfect for characterizing iPS cells, researching behaviors of diseased cells, or screening for drugs to treat disease, the Maestro platform delivers an easy-to-use, compact cellular analysis system suitable for any lab.

Benchling is the leader in cloud-based informatics for life science R&D. The company offers a platform purpose-built for large molecule R&D, incorporating six natively unified applications: Notebook, Molecular Biology, Inventory, Registry, Workflows, and Requests. Over 170,000 scientists use Benchling globally across pharmaceutical corporations, leading biotech companies, and research institutions.

Biobide is a biotechnological company with wide experience using Zebrafish for drug efficacy and toxicity screening as well as disease modelling. All the know-how acquired during years allow us to predict toxicities in a cost-time effective manner, such as developmental toxicity, cardiotoxicity, hepatotoxicity, ototoxicity or neurotoxicity in discovery process.

From drug substance to drug product, discovery to development, small molecule or biologics, BioDuro is your partner for accelerating drug discovery and development and improving efficiency in establishing drug candidate success.

Biognosys is dedicated to advancing innovative mass spectrometry-based tools that provide functional understanding of the proteome. To accelerate drug discovery and development, we work globally alongside 200+ pharma and biotech companies. Our aim is to provide novel and biologically actionable insights through our unique technological and analytical abilities.

BioIVT^® is a trusted supplier of ethically-acquired biospecimens and research services. Disease indications from numerous sample types (biofluids, cells, matched normal/metastasized tissues) are accessible through a network of over 200 clinical sites. With exceptional customer service and quality products and services, BioIVT is your research partner in ELEVATING SCIENCE. 

Biomodels, a pre-clinical CRO is committed to executing successful translational studies. Over its 20 year history, the company has catalyzed the clinical enablement of therapies for many indications. Our oncology offerings include xenograft, orthotopic, PDX, gnotobiotic, and cancer stem cell models to optimize drug development through classical and genomic-based approaches

Biomomentum provides GLP-compliant biomechanical testing services and also manufactures and commercializes testing devices for the mechanical characterization of biomaterials and tissues. The Mach-1™ multiaxial mechanical tester is the only all-in-one device designed for compression, tension, shear, friction, torsion and indentation mapping.

Biopticon develops state-of-the-art scanning devices and data management software. TumorImager-2, Our second-generation handheld imager designed for subcutaneous tumors, generates accurate surface measurements and real-color 3D images. Our xenograft study management program, TumorManager seamlessly integrates study protocols and produce comprehensive tumor metrics, statistical analyses, and publishable reports.  

BlueWasher uses centrifugation to remove liquids from 96, 384 and 1536w plates, achieving residual volumes of 0.1 - 0.3 µl/ well. Low background and variability raise z' for cellular assays by 0.1 - 0.3 so chemists get more reliable compound profiles - screens generate fewer false positives and false negatives.

Boston Healthcare is a global strategy consulting firm that provides market access and value optimization strategies to healthcare innovators. We help clients unlock the value of medical devices, diagnostics, and biopharmaceuticals that have the potential to transform patient care and significantly improve health outcomes.

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and drug discovery. From motor neurons to cortical sub-types, we provide specific models for both disease or normal drug screening. We are dedicated to delivering the highest quality products and custom production of neurons from patient lines.

R&D, preclinical, and clinical level services to the pharmaceutical and biotechnology industry. For the past 20 years we have developed hundreds of customized assays for small and large molecules, biomarkers, diagnostics, and medical devices.  We conduct method development, transfer, validation, and sample analysis. Validated PK/TK, ADA, nAB.

GLP, GCLP, CAP/CLIA 

Caprion Biosciences is a specialty laboratory CRO with an established track record in biomarkers, bioanalytical and immune monitoring services.   Through its advanced immune monitoring platform, Caprion supports the development of vaccine and immunotherapy programs that require the characterization of innate and adaptive immunity.

Cayman Chemical provides discovery and preclinical development services to the global pharmaceutical, biotechnology, and academic markets. Cayman offers comprehensive solutions with competitive pricing, delivers quality science with personalized customer service, and has expertise in bioanalysis and assay development, medicinal chemistry, structure-based drug design, analytical chemistry, and chemical synthesis.

Cellecta is a leading provider of genomic products and services. Our functional genomics portfolio includes gene knockout, knock-in, and knockdown screens; custom and genome-wide CRISPR, RNAi and barcode libraries; construct services; cell engineering; NGS kits: and targeted expression profiling products and services. 

CELLINK was the first bioink company in the world and is today’s leading provider of 3D bioprinters. We design and commercialize bioprinting technologies – enabling researchers to 3D print organs and tissue for applications that span industries, from pharmaceutical to cosmetic. www.cellink.com

Chelatec is a client oriented Contract Research Organization (CRO) specializing in radioactive labelling and preclinical investigations. Our mission is to assist the pharmaceutical and biotechnology industry along the drug development process by using the radioactive tracer in non-clinical studies (ADME/PK) and bioanalyses (immunoassays). Chelatec also proposes services in radiopharmaceuticals R&D.

CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG provides state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia. 

Chemotargets CLARITY integrative analytics platform and Bioinfogate OFF-X portal enable pharmacological profiling and prompt identification of safety signals to de-risk drug R&D.

CLARITY: quantitative target activity and safety prediction of small molecules, including metabolite formation & profiling

OFF-X: delivering actionable toxicity and safety intelligence to pharma researchers and decision makers 

Concept Life Sciences is a knowledge and science-led contract research organisation. We are problem-solvers and trusted partners with a proven track record in life sciences, laboratory based analytical testing and specialist consulting, adding value to our clients’ programmes.

DefiniGEN has a unique platform technology for generating phenotypically validated human cell disease models for a range of prevalent metabolic and liver diseases, to optimize preclinical drug discovery. Our proprietary platform technology delivers our products and custom services including iPSC generation, CRISPR-Cas9 gene-editing, iPSC differentiation and custom disease model development.

Discovery Life Sciences is a global market leader in biospecimen analysis, procurement, and distribution for the pharmaceutical, biotechnology, and diagnostics industries.

Domainex is an integrated drug discovery CRO, offering capabilities in medicinal chemistry, protein expression, assay biology, analytical services and molecular modelling. Our ‘LeadBuilder’ virtual screening and ‘FragmentBuilder’ FBDD platforms will enable your projects to establish hits to kick start your projects to deliver clinical candidates. 

At Elsevier, we want to make analysis easier for everyone working in pharmaceutical development, enabling them to manage their work more efficiently and spend more time making breakthroughs. That's why Elsevier is evolving, creating analytical solutions to serve the needs of drug developers and patients. https://www.elsevier.com

Emulate Inc. is a privately held company that creates living products for understanding how diseases, medicines, chemicals, and foods affect human health. Our Human Emulation System™ is comprised of Organ-Chips, instrumentation, and apps, and sets a new standard for recreating true-to-life human biology.

Expert primate preclinical pharmacology services for drug discovery and toxicology. Access to the largest population of readily available naïve and non-naïve non-human primates in the continental U.S. Dedicated to providing cost-effective quality pharmacokinetic and pharmacodynamic studies with extremely fast turn-around time and on-time delivery. AAALAC accredited, USDA and OLAW compliant.

Epistem is a leading service provider offering a comprehensive range of preclinical research models in oncology, immuno-oncology, inflammatory diseases and skin disorders.  Epistem also offers innovative contract sample analysis including: DNA genotyping, gene expression, IHC and histology, FACS, imaging and Laser Capture Microdissection (LCM) to accelerate drug development programs.

Excelra’s data and analytics solutions empower innovation in life sciences across the value chain from molecule to market. The company’s multifaceted team helps harmonize large volumes of disparate unstructured data; analyze data using cutting-edge AI/ML technologies; and galvanize data-driven decisions to unlock operational efficiencies and accelerate drug development.

Exemplar Genetics develops specialized miniature swine models that are genetically engineered to exhibit a wide variety of human disease states, to provide a more accurate platform to test the efficacy of new medications and devices.  ExeGen® models have applications in cardiovascular, cancer, renal, neurodegenerative, neuromuscular and nervous systems. 

FUJIFILM VisualSonics, Inc is the undisputed world leader in real-time, in vivo, high-resolution, micro-imaging systems, providing modalities specifically designed for preclinical research. These cutting edge technologies allow researchers to conduct research in cardiovascular, cancer and neurobiology areas. VisualSonics platforms combine high-resolution, real-time in vivo imaging at a reasonable cost.

Genesis Drug Discovery & Development (GD³) offers a comprehensive portfolio of CRO drug discovery services. Our experts ensure the efficient development and coordination of your unique program for each step of early drug discovery and pre-clinical drug development. Our portfolio includes disease models for oncology, immunology, metabolic diseases and microbiome.

Hamamatsu Corporation is the North American subsidiary of Hamamatsu Photonics K.K. (Japan), a leading manufacturer of optoelectronic components, cameras, and specialized imaging systems for a wide range of applications. For drug discovery, we offer the FDSS7000 and FDSS/µCELL add-and-read plate readers, which provide fluorescence and luminescence detection for cell-based assays. 

HISTALIM is the European leader in histology, as a service provider, which takes part in R&D projects for pharmaceutical products and biomarkers particularly engaged in the development of new therapies in oncology, immuno oncology, chronic diseases with innovative technologies: IHC, ISH, FISH, TCR, TMA, ...

CRO specializing in immunohistochemistry (IHC), ISH, histology, pathology and image analysis. Non-GLP and GLP support of toxicology studies, a vast array of disease models, human samples for research; with general as well as specialty focus. Excellent turn around times and high quality work.

Hopstem Biotechnology provides high quality Human Neural Progenitor Cells and its unique balanced differentiated neuron cultures (Cortical Neuron, Dopamine Neuron, Motor Neuron, Astrocytes, Microglia), as well as highly consistent 3D cerebral organoids for CNS drug screening and toxicity evaluation. We also provide related screening and toxicity testing service.

immunoSCAPE is a biotechnology start-up which partners with pharmaceutical and biotech companies around the world to optimize their drug pipelines in oncology, infectious and autoimmune diseases. A spin-off from Evan Newell’s lab, immunoSCAPE employs cutting-edge technologies to measure alterations of immune cells and T cell specificity.

Invivoscribe® is a comprehensive CDx partner, providing ISO13485 compliant biomarker development, cGMP manufacturing, regulatory capability, clinical trial services, and global commercialization. We offer internationally standardized testing through our ISO15189 laboratory network. Our Streamlined CDx™ approach has proven successful in approval of the first ever AML companion diagnostic assay.

IONpath™ is a venture-backed, commercial-stage company, founded by Stanford researchers out of the Department of Pathology, focused on revolutionizing pathology with Multiplexed Ion Beam Imaging (MIBI) technology. MIBI is a highly multiplexed imaging platform with unmatched resolution, sensitivity, and throughput. 

We specialize in quantitative multiplexed proteomic applications. We are a full service company providing proteomic characterization for a wide range of samples. We utilize technology leading instrumentation and methodologies, providing sensitive, accurate, and reproducible proteomic characterization.

LabTwin is the world’s first voice-powered lab assistant. It uses AI and voice-recognition technologies to streamline workflow in laboratories in top-tier institutes, such as UCSF, and top 10 pharma companies. LabTwin reduces experimental error, improves R&D efficiency and shortens product development. LabTwin is backed by BCG Digital Ventures and Sartorius.

LifeCanvas Technologies is pioneering in holistic tissue processing and is the only company to own the entire workflow from preservation, clearing, antibody labeling, Refractive Index-matching, to imaging and analysis. By breaking down barriers and empowering researchers with streamlined approaches, we ensure the best results and open new horizons in science. 

Lipotype delivers comprehensive, quantitative lipid analysis services for clinical and biological samples on high-throughput scale. Drawing on many years of cutting edge research, Lipotype offers high quality lipidomics for customers and applications like biomarker identification for clinical research, pharma and biotech companies, or the small-scale profiling needs of academia.

Our new and vibrant company based out of Las Vegas 

We offer a streamlined catalog of CBD products which may assist needs or any issues having to deal with:

• Anxiety • Sleep Disorders • Stress Relief • Depression • Inflammation • Balance energy • Streamline metabolism

Lonza provides the pharma market with the tools that life-science researchers use to develop and test therapeutics. Lonza’s bioscience products and services range from cell culture and discovery technologies for research to quality control tests and software that ensures product quality. Lonza serves customers from companies and research institutions worldwide.

MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, single cell and immune profiling , diabetes, ophthalmology, cardiology, and other rare diseases. 

Medicenna is a clinical stage immuno-oncology company developing an exciting pipeline of highly selective pharmacologically optimized immune modulators.  Our IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines stimulate tumor-killing immune cells and disrupt the tumor microenvironment while synergizing with other cancer immunotherapy platforms for potent, targeted treatment.

Metabolon, Inc. is the world’s leading health technology company advancing metabolomics in precision medicine and life sciences research. Its Precision Metabolomics^™ is a powerful technology for assessing health and delivering biomarker discoveries, innovative diagnostic tests, and valuable data for genomics and population health initiatives.

Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application. Our more than 25 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 2,500 employees in 28 countries.

MIMETAS enables scientists to develop better predictive human tissue & disease models with organ-on-a-chip technology. Our vision is to create the simplest device for the most complex 3D biology. The OrganoPlate® allows perfused 3D cell culture, membrane free co-culture and culture of tubules in a throughput never seen before.

Mispro Biotech Services offers research organizations access to fully-managed & staffed vivarium research facilities with comprehensive animal care & compliance services in support of preclinical drug & product development.

Mission Bio helps researchers unlock single-cell biology for the discovery, development, and delivery of precision medicine. Tapestri, the industry-first single-cell DNA platform, enables accelerated detection of genetic heterogeneity within and across cell populations.  With Mission Bio, researchers have a highly sensitive, targeted, and customizable solution, moving precision medicine forward. 

At MOLECUBES we provide three separate benchtop imagers or “CUBES”. The γ-CUBE (SPECT), β-CUBE (PET) and X-CUBE (CT) are perfectly suited for in vivo multimodal whole body rat and mouse imaging. User-friendliness and expert servicing with no compromise on image quality is what we stand for.

At Molecular Devices, we enable our customers to unravel the complexity of biological systems. We provide platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products empower scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.

MolecularMD develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. MolecularMD integrates gold standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development.

NanoSurface Biomedical is a biotechnology company based in Seattle, WA that develops biomimetic technologies to enhance cell-based assays and accelerate drug development. NanoSurface was founded in 2015. www.nanosurfacebio.com

Ncardia is a stem cell drug discovery and development company. We develop human cellular (disease) biology in optimized assay systems to enable efficacy testing with a better translation into the clinic. Our novel DiscoverHIT Screening, and hiPSC Manufacturing Platform enable flexible solutions for bringing hiPSC models to drug discovery campaigns.

NeuCyte is an innovative biotechnology company focused on CNS drug discovery. Based on its proprietary SynFire® technology for generating human iPSC-derived neurons, NeuCyte has developed a highly functional in vitro platform for disease modeling and neurotoxicity assessment. NeuCyte is actively pursuing programs on Fragile X Syndrome, Epilepsy, ALS and more.

Proprietary MultiBrain® Technology enables simultaneous sectioning and staining of 40 neuronal tissues in one MultiBrain® block, achieving uniform processing across treatment groups. Coupling mass production neurohistologic methods with staining expertise in standard stains, immunohistochemistry and specialty stains for disintegrative degeneration and Alzheimer's pathology, NSA significantly reduces client's R&D cycle times.

Neurotar offers preclinical imaging services based on a unique in vivo microscopy platform. Our most popular assays include trans-BBB PK of biologics, microglia motility in response to laser injury, dendritic spine turnover, peripheral nerve regeneration, and longitudinal quantification of Abeta plaques and Tau tangles in mouse models of Alzheimer's disease.

Nikon Instruments Inc. is the US microscopy arm of Nikon Healthcare, a world leader in the development and manufacture of imaging technology for biomedical applications. Leveraging our expertise in optics, image acquisition and analysis, Nikon is able to offer a wide range of solutions for the regenerative medicine industry.  https://www.microscope.healthcare.nikon.com/

Novabiosis isolates and sells cryopreserved primary human cell types from multiple organs, such as the liver, kidney, lung, and intestine, for the research community.  Check out our HIGH quality plateable hepatocytes with multiple lots and large batch sizes!

CRO/CDMO with more than 40 years of experience, NUVISAN offers a comprehensive set of services to support our client's development projects from molecule to proof-of-concept and beyond. Nuvisan's Preclinical facility in Munich is offering a deep expertise

in invitro/invivo DMPK, QWBA, ADME, Metabolite Identification, Radiosynthesis and Bioanalysis Services.

OcellO offers in vitro assays which recapitulate and quantify complex human biology in a robust and high-throughput format. We test compounds for oncology, immuno-oncology, inflammation and cystopathy indications.

Olink Proteomics provides innovative solutions for targeted human protein biomarker discovery, with rapid, high-throughput immunoassay analysis, exceptional data quality, and minimal sample consumption. Disease or biology-focused panels allow simultaneous analysis of 92 biomarkers with 1 µl of sample, and are available as kits or via our Analysis Service

Olympus is dedicated to your work, vision and science. Through innovation and service, we seek to aide in your discoveries, advance your research, and inspire you to explore new possibilities. Our wide range of imaging solutions are built with the optical excellence and proven application expertise.

OmicScout is a CRO offering protein analytics for drug discovery companies, consulting and data evaluation: Genetic model evaluation; TargetScout™ - target identification, engagement and specificity, SignallingScout™ - lead signaling; KinomeScout™ - lead specificity; BiomarkerScout™ - highly parallel marker quantification at multiple conditions; ProteomeScout™ - targets & biomarkers in different indications

Thanks to RadiomiX signatures, Oncoradiomics provides pharmaceutical companies with an A.I. investigation service that helps with diagnosis, determining responders and monitoring patients.

Enabled by non-invasive extraction of radiomic features from medical imaging, Oncoradiomics expertise discovers biomarkers and helps Pharmaceutical companies make the most accurate decision as fast as possible.

ONI have developed the world’s first desktop microscope capable of achieving 20nm resolution. The Nanoimager suite supports multiple imaging modes including live-imaging, confocal, single-particle tracking, dSTORM, SIM and smFRET. ONI are democratizing a unique combination of powerful imaging solutions for the life sciences and healthcare sectors.

Orbita provides conversational AI technologies and services for healthcare organizations to create  voice- and chatbot-powered virtual assistants for consumer, clinical and business use cases across the enterprise. These solutions increase operational efficiencies and improve consumer and patient experiences in customer service, brand engagement, medication adherence, clinical trials, population health, etc.

Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by breath-based diagnostics, through the development and application of Breath Biopsy®. Breath Biopsy operates by detecting volatile organic compounds produced as the end product of metabolic processes within the body or chemicals from external sources.

PBL Assay Science provides an expanded range of assay solutions including single and multiplex cytokine quantification, ultrasensitive biomarker measurement services, low-pg/ml interferon ELISA kits, high quality interferon-related protein and antibody reagents, and a variety of cell-based assay services. PBL continually strives to maximize the value of your crucial biological samples. 

Peira provides equipment for pre-clinical and pharmaceutical laboratories. They develop, produce and offer hand held devices for small rodent tumor volume measurements, electrodes and connectors for monitoring animals, rotating and translating animal cage systems, laboratory reactors,  magnetic stirrers and mixers. Peira also provides engineering and production for custom made systems.

PharmaLegacy Laboratories is a preclinical CRO providing in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program.

PharmaLegacy has over 300 validated animal models of disease spanning over 40 different diseases in the fields of cancer, auto-immunity and inflammation. 

PhysIQ transforms wearable biosensor data into actionable insight. Our device-agnostic platform, coupled with our portfolio of FDA-cleared AI-based physiology analytics, continuously captures data from wearable biosensors and transforms it into patient insight. We provide this solution to life science companies who are integrating biosensor data into their clinical trials.

We are a global technology company providing the life sciences industry with solutions in big data analytics, management, visualization, and warehousing. Our offerings reduce risks, improve data quality, shorten time to market, and generate better insights from R&D and regulatory data.

ProImmune is committed to providing unique solutions for preclinical and clinical immunology research to better understand and manage adaptive immune responses.  ProImmune offers a comprehensive and integrated antigen characterization platform, and products and services for tracking antigen-specific immune responses with state-of-the-art ELISpot and flow cytometry techniques.

ProQinase is a service provider supporting the preclinical development of cancer therapeutics. Our portfolio comprises biochemical, biophysical and cell-based assays as well as in vivo tumor models, thus providing comprehensive testing from one single source. Our service is completed by individualized solutions and the development of custom-tailored state-of-art assays.

ProteoGenex is an established innovative provider of human biological specimens collected under strict ethical standards. ProteoGenex offers exclusive custom-designed collection service as well as access to our unique broad Biorepository of well-defined validated clinical specimens including tissues, serum/plasma, bone marrow, RNA/DNA supported by patient's clinical history documentation and pathology information.

We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our capabilities include behavioral testing, electrophysiology, EEG, histology, molecular biology and microdialysis. Using proprietary technology platforms, we also pioneered the translation of rodent behavioral responses into robust, high-throughput, high content phenotyping and drug discovery.

Quansys Biosciences is dedicated to the development and manufacture of multiplexed assays for protein quantification. The Quansys Q-Plex and Q-View technologies aid researchers in better understanding disease. These technologies include multiplex and singleplex assays, imaging hardware and software, built to maximize the quantity and quality of data from biological samples.

Quanterix advances the science of precision health by digitizing biomarker analysis. Our digital health solution, Simoa®, has the potential to change the way healthcare is provided by enabling researchers to closely examine the continuum from health to disease through ultrasensitive detection of biomarkers and to accelerate drug development and approval.

REPROCELL is a worldwide leader in iPSC and drug discovery. Our products and services, including  an extensive human tissue network, RNA-based reprogramming and stem cell services, CRISPR/Cas9 genome editing, precision genome sequencing, drug discovery assays and 3D cell culture models, provide our clients unrivalled solutions for pre-clinical testing.

RICOH is leading innovation in the biomedical field today by applying its expertise in printing technology. Using a new printhead specifically designed to print living cell suspensions with single cell precision, we are presenting a collaborative work with Elixirgen Scientific to generate Cell Chips with multiple, disease-derived iPS cells.

Established in 1999, Sai Life Sciences has >2,000 employees located at 4 R&D and manufacturing sites in India. Sai provides high-value services in medicinal chemistry, custom synthesis, pharmacology, DMPK, toxicology, CADD, pre-clinical formulations, CMC and GMP manufacturing, covering the full spectrum of the drug discovery and development pipeline.

SEKISUI XenoTech is a global CRO for ADME/DMPK/DDI testing and test systems. Specializing in Enzyme Inhibition and Induction, Drug Transporters, Metabolite ID and Metabolic Stability testing, as well as an extensive selection of Hepatocytes and DMPK-focused test systems, we are your trusted partner to efficiently move your drug through development.

Sengenics is a functional proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded and functional proteins. KREX™ was invented and patented by Professor Jonathan Blackburn at the University of Cambridge. 

Key applications of KREX™ are autoantibody biomarker-based companion diagnostics and autoantibody biomarkers for early diagnosis.

SeraCare Life Sciences is a leading partner to global in vitro diagnostics manufacturers and clinical testing laboratories. For over 30 years we have focused on the research and development of technologies and products to improve the quality, accuracy, and confidence of diagnostic tests.

Medicilon offers fully integrated pharmaceutical services for the global scientific community. We focus on providing an exceptional client-centered experience and advancing the drug discovery process. Since 2004, our integrated services are uniquely designed to help clients developing their research and discovery programs from initial idea stage to IND filing phase.

MilliporeSigma® offers an unparalleled level of peer support, quality tools, and services. Our immunoassay offering includes MILLIPLEX® map biomarker panels, Luminex® xMAP® technology, ELISAs, RIAs, SMCxPRO™ instrument and custom assay development solutions to meet your specific experimental needs. Therapeutic areas: metabolic disease, inflammation, immunology, neuroscience, oncology, and toxicity.

At STEMCELL, we are driven by our mission to advance scientific progress. We offer more than 2,500 tools and services to support research globally, including 3D culture systems that enable more physiologically relevant models of development and disease states. Inspired by knowledge, innovation and quality, we are Scientists Helping Scientists.  

StemoniX® is transforming how medicine is discovered. We provide functioning human microOrgans®, such as microBrain® and microHeart®, in pre-plated high throughput screening formats for drug discovery and toxicology research. We also partner with organizations to apply our expertise for modeling diseases, screening compounds, and supplying custom microOrgans. Visit stemonix.com.

Studylog’s Animal Study Software manages the entire animal study workflow, reducing study-related labor and time by half for most customers. Its comprehensive functionality, ease-of-use and flexibility make animal researchers' jobs easier, more organized and productive. Studylog also securely preserves study information and results for searching and use forever.

Sygnature Discovery, a leading integrated drug discovery CRO, offers a range of services across medicinal and computational chemistry, in vitro and in vivo pharmacology as well as DMPK. Since 2011, 28 compounds discovered by Sygnature have entered pre-clinical development; so far, 14 of these have progressed to clinical trials.

SynVivo’s 3D tissue models recreate complex in vivo microvasculature including scale, morphology, hemodynamic shear stress and cellular interactions with real-time visualization and quantitation in a microfluidic chip.  These models accelerate drug delivery and drug discovery by providing a biologically realistic microenvironment that more accurately depicts in vivo reality.

Taconic Biosciences is a fully-licensed, leader in genetically engineered rodent models and services. Taconic helps researchers acquire, generate, breed, test, and distribute research models worldwide.

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore gene discovery, regulation, and function. As a Takara Bio Group member, TBUSA is part of a company that holds a global leadership position and is committed to developing high-quality innovative tools and services to accelerate discovery.

The Jackson Laboratory (www.jax.org) is an independent, nonprofit biomedical research organization with a National Cancer Institute-designated Cancer Center, and facilities in Bar Harbor, ME, Sacramento, CA, and a genomic medicine institute in Farmington, CT. Its mission is to discover precise genomic solutions that empowers the biomedical community worldwide.

Toxikon is a leading preclinical contract research organization (CRO) providing in vivo, in vitro, and analytical testing services for the pharmaceutical, biotechnology, and medical device industries – helping those companies gain approval for their products quickly and bring them to market successfully.

Cell-able® 3D-culture plate will provide great advantages to users such as “Easy handling”, “High-throughput” and “Good reliability” with forming cell-spheroids of uniform size attaching to the micro-patterned culture surface.

Cell-able® technology has been developed by Toyo Gosei, which has a worldwide large share and expertise in photosensitive-materials used for photoresists.

Trans-Hit Bio is the worldwide biospecimen access CRO with a most extensive collection capability for biospecimens and clinical samples through an unrivaled worldwide partnered-network state-of-the-art Academic  and Hospital-based Biospecimen Providers. Led by a team of expert scientists THB facilitates direct interactions between End-users and academic and hospital-based biobanks.

TTP is an independent technology company where scientists and engineers collaborate to invent, design, develop new products and technologies. Working across a wide spectrum of industries including health, telecoms, industrials and consumer, TTP creates breakthrough solutions that bring strong commercial value to clients and the benefits of technology to all.

Ultivue is illuminating the transformative power of protein biomarkers.  Ultivue’s InSituPlex® technology enables scientists to unmask and analyze the true biological context of tissue samples. Ultivue’s UltiMapper™ kits provide researchers with a simple, fast, fully optimized and biologically relevant panels to gain a deeper understanding of the tumor micro-environment.

Valorem Reply is a digital transformation firm focused on driving change with unique digital solutions, strategic business models and design-led user experiences. Through the expertise of our people and the power of Microsoft technologies, our innovative strategies and solutions securely and rapidly transform the way our clients do business.

ViQi provides cloud-based large-scale image visualization and analysis software for CRO, biotech, and medical science companies. Using this customizable software, researchers and developers can easily visualize, analyze, store, and collaborate on data in one central web-based repository. ViQi supports scientific images and data files in any size and number.

Visiopharm® is a world leader in Augmented Pathology™ solutions; comprising precision pathology and high-throughput pathology for tissue-diagnostics and research for hospitals, biopharmaceutical companies, and research institutions.

Our software is featured in more than 1300 scientific publications and is compatible with leading slide scanner manufacturers, data management software, and staining providers.

YAMAHA CELL HANDLER^TM screens and transfers a targeted cells to multiwell plates and processes images rapidly and accurately.

Applicable cells: single cells, organoids, spheroids, ex vivo tissues, etc.

Applications: screening for clones, drug discovery, drug sensitivity testing, phenotypic screening, omics analysis, etc. 

ZeClinics is a biotech company specialised in pre-clinical and early-phase drug discovery. Our services are based on alternative in-vivo models and include toxicity and efficacy assays as well as CRISPR gene-editing. We are proficient in multiple therapeutic areas, including cardiovascular, neurological, oncologic, ophthalmologic and genetic disorders among other ready-to-use diseases.